A Pilot Study of the Clinical Implementation of the Carevive Survivor Care Planning System
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Stage I Breast Cancer
- Sponsor
- Sidney Kimmel Cancer Center at Thomas Jefferson University
- Enrollment
- 40
- Locations
- 2
- Primary Endpoint
- Patient reported activation as measured by the Patient Activation Survey
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
This pilot clinical trial studies how well the Carevive Survivor Care Planning System works in improving quality of life in breast cancer survivors. A personalized survivor care plan includes a summary of a patient's cancer treatment and a customized survivor care plan and may provide beneficial information and resources.
Detailed Description
PRIMARY OBJECTIES: I. To evaluate the feasibility of using the Carevive Survivor Care Planning System (SCPS) during the follow-up visit for breast oncology survivors treated in a university cancer center or a community medical center. II. To evaluate survivors' perceptions of the usability of the Carevive technology. III. To evaluate their perceptions of the acceptability (perception of benefit) of the treatment summary and survivor care plan. SECONDARY OBJECTIVES: I. Examine the psychometrics of surveys developed for this research. II. Compare participants' perceptions of the care received under the Carevive system with clinician documentation. III. Compare clinician documentation of care received by this sample with documentation of care provided for historical controls at each site.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Prospective study: completed primary treatment for breast malignancies; receive survivorship care at Thomas Jefferson University (TJU) or Reading Health System (RHS)
- •Prospective study: individuals will have pathologically confirmed breast cancer (stages I-III)
- •Prospective study: Able to understand and read English
- •Prospective study: Physically capable of using a tablet computer (no severe visual, hearing, or hand motor deficits)
- •Retrospective chart review: Individuals will have pathologically confirmed breast cancer or gynecological (GYN) malignancies including uterine, ovarian, or cervical cancers, stages I-III; treated in the previous two years (2013-2014)
Exclusion Criteria
- •Women who are pregnant
- •Vulnerable populations: cognitively impaired; prisoners; terminally ill; elderly and infirm; drug addicts
Outcomes
Primary Outcomes
Patient reported activation as measured by the Patient Activation Survey
Time Frame: Up to 1 month
Survivor reported outcomes will be evaluated.
Standard deviation will calculated to identify low-score items indicating problems that need to be addressed.
Time Frame: Up to 1 year
Feasibility information will be auto-generated by the Carevive system.
Patient reported knowledge and confidence as measured by the Knowledge and Confidence Survey
Time Frame: Up to 1 month
Survivor reported outcomes will be evaluated.
Patient reported health behavior as measured by the Health Behavior Survey
Time Frame: Up to 1 month
Survivor reported outcomes will be evaluated.